TickerFactsScreenerDevelopers

Edesa Biotech, Inc. (EDSA) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2011: $4.15M2012: $999.0K2013: $7.86M2014: $8.77M2015: $3.96M2016: $7.42M2017: $5.00M2018: $3.37M2019: $5.03M2020: $7.21M2021: $7.84M2022: $7.09M2023: $5.40M2024: $1.00M2025: $10.80M$10.80M
2011Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$10.80M+980.0%
2024$1.00M-81.5%
2023$5.40M-23.8%
2022$7.09M-9.5%
2021$7.84M+8.7%
2020$7.21M+43.4%
2019$5.03M+49.4%
2018$3.37M-32.7%
2017$5.00M-32.6%
2016$7.42M+87.5%
2015$3.96M-54.9%
2014$8.77M+11.6%
2013$7.86M+686.8%
2012$999.0K-75.9%
2011$4.15M—